查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951871

醫藥包裝市場分析及預測（至2035年）：依類型、產品類型、材質、技術、應用、組件、最終用戶、功能、製程及解決方案分類

Pharmaceutical Packaging Market Analysis and Forecast to 2035: Type, Product, Material Type, Technology, Application, Component, End User, Functionality, Process, Solutions
出版日期: | 出版商: Global Insight Services | 英文 300 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，醫藥包裝市場規模將從2024年的1,172億美元成長至2,075億美元，年複合成長率約為5.9%。醫藥包裝市場涵蓋了保護、保存藥品並確保其安全性和有效性的各種解決方案。該市場包括由玻璃、塑膠、紙張和金屬等材料製成的一級、二級和三級包裝。市場的主要促進因素包括藥品產量不斷成長、監管要求日益嚴格以及生物製藥的興起。永續材料和智慧包裝的創新正在重塑市場，滿足對環保和以患者為中心的解決方案的需求。

受包裝材料創新和永續性的推動，醫藥包裝市場正經歷強勁成長。初級包裝在性能方面發揮主導作用，其中泡殼包裝和藥瓶對於藥品的保護和便利性至關重要。泡殼包裝因其劑量精準和防篡改特性而備受青睞，已成為醫藥供應鏈中不可或缺的一部分。其次，二級包裝市場也呈現顯著成長，尤其是紙盒和包裝盒，它們不僅提升了品牌形象，還能提供額外的保護。對環保和可生物分解包裝解決方案的需求不斷成長，反映了醫藥產業向永續性的轉型。可生物分解薄膜和可回收材料的興起尤其反映了這一趨勢。此外，採用RFID技術的智慧包裝解決方案也日益受到重視，因為它們有助於提高供應鏈效率並確保產品完整性。這些進步凸顯了市場的動態特性及其應對力。

市場區隔
類型 泡殼包裝、條狀包裝、管瓶、安瓿、瓶子、小袋、藥筒、藥管
產品 初級包裝、二級包裝、三級包裝
材質類型 玻璃、塑膠、金屬、紙張和紙板
科技 活性包裝、智慧包裝、調氣包裝
目的 口服藥物、注射、外用藥物、吸入藥物、經皮藥物、滴鼻劑、眼藥水和靜脈注射藥物
成分 蓋子與封口裝置、標籤、配件
最終用戶 製藥公司、合約包裝、零售藥局、醫院藥房
功能 防篡改、兒童安全、老年人友善設計
製造過程 吹灌封式無菌灌裝
解決方案 永續包裝，智慧包裝

醫藥包裝市場以產品組合多元化為特徵，並高度重視創新和永續性。環保包裝解決方案和先進技術的推出正在影響市場佔有率。定價策略競爭日益激烈，各公司在成本效益、品質和合規性之間尋求平衡。新產品上市的重點在於提高藥物安全性和延長保存期限，反映出市場正朝著更先進的包裝解決方案發展。競爭標竿研究揭示了充滿活力的市場格局，主要企業不斷加大研發投入以保持競爭優勢。監管影響至關重要，嚴格的指導方針塑造全球包裝標準。北美和歐洲等法規結構健全的地區正經歷強勁的市場成長。亞太地區的新興市場也受惠於醫療保健投資的不斷成長而蓬勃發展。監管標準與技術進步之間的相互作用至關重要，這不僅為市場參與企業帶來了挑戰，也帶來了機會。

主要趨勢和促進因素：

受多種關鍵趨勢和促進因素的影響，醫藥包裝市場正經歷蓬勃發展。其中一個顯著趨勢是對永續和環保包裝解決方案的需求日益成長。隨著人們對環境問題的日益關注，製藥公司正優先考慮使用可生物分解和可回收材料，以減少碳足跡。嚴格的監管要求和消費者對更環保替代品的偏好進一步推動了這一轉變。技術創新也是一項關鍵趨勢，智慧包裝解決方案正日益受到青睞。QR碼、RFID標籤和NFC技術的整合提高了供應鏈透明度，並確保了產品的真實性。這些創新不僅提高了病患安全，還有助於更有效率的庫存管理。慢性病的增加和人口老化是推動市場發展的關鍵因素。這種人口結構的變化需要增加藥品產量，從而推動了對能夠確保藥物穩定性和安全性的包裝解決方案的需求。此外，個人化醫療和生物製藥的興起也推動了針對特定藥物配方的專用包裝解決方案的開發。在新興市場，不斷擴大的醫療基礎設施和藥品可近性的提高正在創造盈利的商機。 「投資這些地區的公司預計將佔據可觀的市場佔有率。此外，居家醫療和自我用藥的日益普及，推動了對方便用戶使用型包裝設計的需求，這些設計能夠提高患者的依從性和便利性。隨著藥品包裝市場的不斷發展，那些專注於創新和永續性的公司將在未來的成長中佔據有利地位。」

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 泡殼包裝
    • 條狀包裝
    • 管瓶
    • 安瓿
    • 瓶子
    • 小袋
    • 墨水匣
    • 管子
  • 市場規模及預測：依產品分類
    • 初級包裝
    • 二級包裝
    • 三級包裝
  • 市場規模及預測：依材料類型分類
    • 玻璃
    • 塑膠
    • 金屬
    • 紙和紙板
  • 市場規模及預測：依技術分類
    • 活性包裝
    • 智慧包裝
    • 調氣包裝
  • 市場規模及預測：依應用領域分類
    • 口服藥物
    • 注射
    • 外用藥物
    • 肺
    • 經皮吸收
    • 鼻腔
    • 眼科
    • 靜脈注射藥物
  • 市場規模及預測：依組件分類
    • 瓶蓋和封口
    • 標籤和配件
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 合約包裝
    • 零售藥房
    • 醫院藥房
  • 市場規模及預測：依功能分類
    • 防篡改功能
    • 兒童安全包裝
    • 對於老年人
  • 市場規模及預測：依製程分類
    • 吹塑-灌封
    • 無菌灌裝
  • 市場規模及預測：按解決方案分類
    • 永續包裝
    • 智慧包裝

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Gerresheimer
  • West Pharmaceutical Services
  • Amcor
  • Berry Global
  • Schott
  • Aptar Group
  • SGD Pharma
  • Nipro
  • Stevanato Group
  • Catalent
  • Vetter Pharma
  • Datwyler
  • Ompi
  • West Rock
  • CCL Industries
  • Ardagh Group
  • Gerresheimer Bunde
  • Bormioli Pharma
  • Nemera
  • Klockner Pentaplast

第9章：關於我們

簡介目錄
Product Code: GIS20240

Pharmaceutical Packaging Market is anticipated to expand from $117.2 billion in 2024 to $207.5 billion by 2034, growing at a CAGR of approximately 5.9%. The Pharmaceutical Packaging Market encompasses solutions designed to protect and preserve pharmaceutical products, ensuring their safety and efficacy. This market includes primary, secondary, and tertiary packaging, using materials such as glass, plastic, paper, and metal. Key drivers include increased drug production, stringent regulatory requirements, and the rise of biologics. Innovations in sustainable materials and smart packaging are shaping the market, catering to the demand for eco-friendly and patient-centric solutions.

The Pharmaceutical Packaging Market is experiencing robust growth, driven by innovation in packaging materials and sustainability trends. The primary packaging segment leads in performance, with blister packs and bottles being pivotal due to their protective qualities and convenience. Blister packs are favored for their dosage accuracy and tamper evidence, making them indispensable in the pharmaceutical supply chain. Following closely, the secondary packaging segment shows impressive growth, particularly with cartons and boxes, which enhance branding and provide additional protection. The demand for eco-friendly and biodegradable packaging solutions is increasing, reflecting the industry's shift towards sustainability. This trend is particularly evident in the rise of biodegradable films and recyclable materials. Moreover, smart packaging solutions, such as those incorporating RFID technology, are gaining prominence due to their ability to enhance supply chain efficiency and ensure product integrity. These advancements underscore the market's dynamic nature and its responsiveness to evolving consumer and regulatory demands.

Market Segmentation
TypeBlister Packaging, Strip Packaging, Vials, Ampoules, Bottles, Sachets, Cartridges, Tubes
ProductPrimary Packaging, Secondary Packaging, Tertiary Packaging
Material TypeGlass, Plastic, Metal, Paper & Paperboard
TechnologyActive Packaging, Intelligent Packaging, Modified Atmosphere Packaging
ApplicationOral Drugs, Injectable, Topical, Pulmonary, Transdermal, Nasal, Ocular, IV Drugs
ComponentCaps & Closures, Labels & Accessories
End UserPharmaceutical Companies, Contract Packaging, Retail Pharmacy, Hospital Pharmacy
FunctionalityTamper-Evident, Child-Resistant, Senior-Friendly
ProcessBlow-Fill-Seal, Aseptic Filling
SolutionsSustainable Packaging, Smart Packaging

The pharmaceutical packaging market is characterized by a diverse array of product offerings, with significant emphasis on innovation and sustainability. Market share is influenced by the introduction of eco-friendly packaging solutions and advanced technologies. Pricing strategies are increasingly competitive, with companies striving to balance cost-effectiveness with quality and compliance. New product launches focus on enhancing drug safety and extending shelf life, reflecting a shift towards more sophisticated packaging solutions. Competition benchmarking reveals a dynamic landscape, with leading firms continually investing in R&D to maintain a competitive edge. Regulatory influences play a critical role, with stringent guidelines shaping packaging standards globally. The market is witnessing robust growth in regions with strong regulatory frameworks, such as North America and Europe. Emerging markets in Asia-Pacific are also gaining traction, driven by increasing healthcare investments. The interplay of regulatory standards and technological advancements is pivotal, offering both challenges and opportunities for market participants.

Geographical Overview:

The pharmaceutical packaging market is witnessing notable growth across various regions, each presenting unique opportunities. North America remains at the forefront, driven by advanced healthcare infrastructure and stringent regulatory standards. The region's focus on sustainable packaging solutions further propels market expansion. In Europe, the market is bolstered by increasing demand for innovative packaging technologies, coupled with a strong emphasis on environmental sustainability. The Asia Pacific region is experiencing rapid growth, fueled by rising healthcare expenditure and expanding pharmaceutical manufacturing. Emerging economies such as India and China are pivotal to this growth, with their robust pharmaceutical industries and increasing investment in packaging technologies. Latin America and the Middle East & Africa are emerging as potential growth pockets. In Latin America, the market is supported by a growing pharmaceutical sector and increasing demand for modern packaging solutions. Meanwhile, the Middle East & Africa are witnessing increased investment in healthcare infrastructure, enhancing the region's market prospects.

Global tariffs and geopolitical tensions are significantly influencing the Pharmaceutical Packaging Market. In Japan and South Korea, firms are navigating increased tariffs by enhancing local production capabilities and investing in sustainable packaging innovations. China's strategy focuses on boosting domestic manufacturing resilience amidst export restrictions, while Taiwan leverages its advanced technology sector to maintain competitive advantage despite geopolitical uncertainties. The parent market is experiencing robust growth driven by rising healthcare demands and regulatory advancements. By 2035, the market is expected to evolve towards greater sustainability and digital integration, with Asia-Pacific playing a pivotal role. Middle East conflicts continue to pose risks to global supply chains, potentially affecting energy prices and raw material costs, thereby influencing production and logistics strategies in the pharmaceutical packaging sector.

Key Trends and Drivers:

The pharmaceutical packaging market is experiencing dynamic growth, driven by several key trends and drivers. One prominent trend is the increasing demand for sustainable and eco-friendly packaging solutions. As environmental concerns escalate, pharmaceutical companies are prioritizing biodegradable and recyclable materials to reduce their carbon footprint. This shift is further supported by stringent regulatory requirements and consumer preferences for greener alternatives. Technological advancements are another significant trend, with smart packaging solutions gaining traction. The integration of QR codes, RFID tags, and NFC technology enhances supply chain transparency and ensures product authenticity. These innovations not only improve patient safety but also streamline inventory management. The growing prevalence of chronic diseases and an aging population are crucial drivers for the market. This demographic shift necessitates increased production of pharmaceuticals, thereby boosting demand for packaging solutions that ensure drug stability and safety. Additionally, the rise of personalized medicine and biologics is encouraging the development of specialized packaging solutions tailored to specific drug formulations. Emerging markets present lucrative opportunities as healthcare infrastructure expands and access to medicines improves. Companies investing in these regions are poised to capture significant market share. Furthermore, the trend towards home healthcare and self-administration of medications is driving demand for user-friendly packaging designs that enhance patient adherence and convenience. As the pharmaceutical packaging market continues to evolve, companies focusing on innovation and sustainability are well-positioned for future growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Material Type
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Component
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Process
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Blister Packaging
    • 4.1.2 Strip Packaging
    • 4.1.3 Vials
    • 4.1.4 Ampoules
    • 4.1.5 Bottles
    • 4.1.6 Sachets
    • 4.1.7 Cartridges
    • 4.1.8 Tubes
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Primary Packaging
    • 4.2.2 Secondary Packaging
    • 4.2.3 Tertiary Packaging
  • 4.3 Market Size & Forecast by Material Type (2020-2035)
    • 4.3.1 Glass
    • 4.3.2 Plastic
    • 4.3.3 Metal
    • 4.3.4 Paper & Paperboard
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Active Packaging
    • 4.4.2 Intelligent Packaging
    • 4.4.3 Modified Atmosphere Packaging
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oral Drugs
    • 4.5.2 Injectable
    • 4.5.3 Topical
    • 4.5.4 Pulmonary
    • 4.5.5 Transdermal
    • 4.5.6 Nasal
    • 4.5.7 Ocular
    • 4.5.8 IV Drugs
  • 4.6 Market Size & Forecast by Component (2020-2035)
    • 4.6.1 Caps & Closures
    • 4.6.2 Labels & Accessories
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Contract Packaging
    • 4.7.3 Retail Pharmacy
    • 4.7.4 Hospital Pharmacy
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Tamper-Evident
    • 4.8.2 Child-Resistant
    • 4.8.3 Senior-Friendly
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Blow-Fill-Seal
    • 4.9.2 Aseptic Filling
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Sustainable Packaging
    • 4.10.2 Smart Packaging

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Material Type
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Component
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Process
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Material Type
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Component
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Process
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Material Type
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Component
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Process
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Material Type
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Component
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Process
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Material Type
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Component
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Process
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Material Type
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Component
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Process
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Material Type
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Component
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Process
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Material Type
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Component
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Process
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Material Type
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Component
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Process
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Material Type
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Component
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Process
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Material Type
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Component
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Process
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Material Type
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Component
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Process
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Material Type
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Component
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Process
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Material Type
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Component
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Process
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Material Type
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Component
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Process
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Material Type
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Component
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Process
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Material Type
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Component
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Process
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Material Type
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Component
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Process
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Material Type
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Component
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Process
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Material Type
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Component
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Process
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Material Type
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Component
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Process
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Material Type
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Component
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Process
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Material Type
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Component
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Process
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Material Type
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Component
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Process
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Gerresheimer
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 West Pharmaceutical Services
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Amcor
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Berry Global
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Schott
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aptar Group
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 SGD Pharma
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Nipro
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Stevanato Group
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Catalent
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Vetter Pharma
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Datwyler
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Ompi
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 West Rock
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 CCL Industries
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Ardagh Group
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Gerresheimer Bunde
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bormioli Pharma
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Nemera
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Klockner Pentaplast
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us